All cancer types
Open
Phase 1/2
This study is looking at a drug called T3P-Y058-739 (T3P) for solid cancers.
A solid cancer is any cancer apart from a blood cancer such as leukaemia, lymphoma and myeloma.
Recruitment start: 2 June 2022
Recruitment end: 28 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kevin Harrington
T3 Pharmaceuticals AG
IQVA BIOTECH
Last reviewed: 14 October 2024
CRUK internal database number: 18049